1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Cardiovascular Disease Prevention: new trials by email Literature Review of Cardiovascular Disease Prevention trials Research Report on Cardiovascular Disease Prevention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV Semaglutide (Rybelsus®), Placebo - HIV, Alcohol | Phase 2 | Recruiting | Vanderbilt University Medical Center | 200 | 2026-04-17 | 2026-05-26 |
Cardiovascular Diseases (1) · Cigarette Smoking (1) · Smoking (1)
Behavior (1) · Tobacco Smoking (1) · Tobacco Use (1)
semaglutide (1)
Vanderbilt University Medical Center (1)
United States (1)
P60AA032176 (1)